According to recently released World Health Organization data on mortality, in 2015 there were 5.9 million deaths among children under the age of 5 years, and 2.7 million occurred in the neonatal period (1). Globally, pneumonia was the leading cause of under-5 deaths, particularly in sub-Saharan Africa countries, where the decrease in child mortality from pneumonia from 2010 to 2015 was reduced compared with the already modest 6% observed globally (1). Although improvements in survival are directly linked to socioeconomic progress and concurrent improvements in healthcare systems in low-income settings, premature deaths among children can be prevented with access to simple and affordable interventions. In the case of preterm birth (2) and pediatric respiratory diseases (3), a particularly effective treatment is continuous positive airway pressure (CPAP), in particular bubble CPAP (4), with demonstrated efficacy in low-income countries (LICs) (5, 6). The simplest and cheapest way to provide CPAP is to use the central gas pressure source in a hospital, and as such, hospitals would seem to be the most suitable setting in LICs. Nevertheless, because the number of hospitals in LICs with central gas supply facilities is exceedingly low, CPAP is usually restricted to private medical facilities in urban settings and therefore is unavailable to the majority of the population receiving care in extremely underserviced regional hospitals and rural healthcare sites. Hence, readily extending potential CPAP treatment relies on the provision of stand-alone devices incorporating autonomous gas pressure sources. There are three potential options to provide healthcare centers in LICs with the CPAP devices they cannot afford: